Clinical Genomics for Cancer Diagnostics

-

How can information generated from advanced genomic profiling technology be turned into something clinically actionable? Successfully delivering personalized cancer medicine to patients requires a thorough understanding of how gene expression patterns relate to cancer therapy response as well as the ability to determine which information is most relevant to an individual's disease. The evolving role of the physician in cancer treatment has become equally important and communicating test results in a concise manner is a largely unmet need. The Inaugural Clinical Genomics for Cancer Diagnostics meeting will look at novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. Hotspot testing will be compared to comprehensive genome profiling and emerging technologies will be explored. Considerations for molecular test development, result reporting, and patient stratification will be also addressed. Using genomic information in cancer management presents many operational challenges, but also offers an unprecedented opportunity to take the trial and error out of cancer treatment.

Location:
Seaport Hotel
USA
USA


Organizer: Cambridge Healthtech Institute

23 Sep 2013

Upcoming Featured Events
1 Next 
Labcyte-University of Edinburgh Genomics Symposium 201628 Sep 2016
ASHG 201618 Oct 2016
PEGS Europe31 Oct 2016
Neuroscience 201612 Nov 2016
SLAS 20174 Feb 2017
Pittcon Conference and Expo 20175 Mar 2017
65th ASMS Conference4 Jun 2017



Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement